Vancomycin‐ResistantEnterococcus faeciumMeningitis Successfully Managed with Linezolid: Case Report and Review of the Literature
Clinical Infectious Diseases2001Vol. 33(4), pp. 477–482
Citations Over TimeTop 10% of 2001 papers
Abstract
Enterococci cause serious illness in immunocompromised patients and severely ill, hospitalized patients. Resistance to vancomycin has increased in frequency during the past few years. Limited therapeutic options are available for vancomycin-resistant enterococcal infections and the optimum therapy has not been established. We report a case of nosocomial vancomycin-resistant Enterococcus faecium meningitis in the setting of hyperinfection with Strongyloides stercoralis that was successfully treated with linezolid. We also review the previously reported cases of vancomycin-resistant E. faecium meningitis.
Related Papers
- → The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure(2014)25 cited
- → Efficacy of Linezolid Alone or in Combination with Vancomycin for Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus(2003)77 cited
- → Emergence of increasing linezolid-resistance in enterococci in a post-outbreak situation with vancomycin-resistantEnterococcus faecium(2007)39 cited
- → Emergence of linezolid-resistant Enterococcus faecium during treatment of enterococcal infections(2003)24 cited
- Comparison of Linezolid vs.Vancomycin in the Treatment of Retention Catheterization Infection Induced by MRSA(2011)